|  | Cancer | Chemotherapy

Hepatic Arterial Infusion (HAI) Chemotherapy: Role of Infusion Pumps

What Is HAI?

Hepatic Arterial Infusion delivers chemotherapy directly into the hepatic artery, which supplies ~75% of liver blood flow (vs. 25% portal venous). Tumors derive >90% of blood supply from hepatic artery → high tumor drug concentration, low systemic exposure.

Infusion Pump Functions in HAI

Common HAI Agents & Regimens

  • Floxuridine (FUDR): Classic HAI agent; continuous infusion via implanted pump; requires hepatic function monitoring.
  • Oxaliplatin, Irinotecan, Gemcitabine: Investigated in modern protocols.
  • Heparin: Co-infused (500–1000 U/hr) to prevent hepatic artery thrombosis.

Clinical Outcomes

  • Higher response rates in colorectal liver metastases vs. systemic chemo alone.
  • Conversion to resectability in initially unresectable disease.
  • Reduced systemic side effects (alopecia, myelosuppression, neuropathy).
  • Requires specialized surgical placement (gastroduodenal artery ligation, catheter positioning) and multidisciplinary management.

Pump Types

  • Implantable (e.g., Codman 3000, Medtronic SynchroMed): Subcutaneous pocket, refilled percutaneously; months-years.
  • External Ambulatory (e.g., CADD-Solis, BodyGuard): Short-term, wearable.

Chemotherapy - Related Articles

Health Sciences © https://www.222health.com

FunctionBenefit
Precise Flow ControlMaintains constant drug concentration; avoids peaks (toxicity) and troughs (subtherapeutic).
Programmable SchedulesComplex regimens (continuous, pulsed, cyclic) executed accurately.
Adjustable RatesReal-time dose modification based on toxicity/response.
Safety AlarmsOcclusion, air-in-line, low battery, reservoir empty, pressure limits – prevent over/under-dosing.
Portability (Ambulatory Pumps)Patient mobility, outpatient treatment, quality of life.
Multi-Channel CapabilitySimultaneous infusion of chemo + heparin (catheter patency) + other meds.